In a recent interview, the Director of the FDA’s Center for Drug Evaluation and Research (CDER), Dr. Janet Woodcock, was given the opportunity to share her vision for the center in 2015. When asked where she would most like to see advances in the realm of drug discovery, research, and development, Dr. Woodcock pointed to the need to reform the clinical trial system to reduce wastefulness. She cited CTTI’s role in analyzing and innovating different components of trial conduct and design; “I think we’ve made significant progress there,” stated Woodcock.

To read the transcript of the interview in full, click here.